A principal component analysis of coagulation after trauma

Journal of Trauma and Acute Care Surgery

Volumn 74, Issue 5, 2013, Pages 1223-1230

  Kutcher, Matthew E ^a   Ferguson, Adam R ^b   Cohen, Mitchell J ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coagulopathy; fibrinolysis; principal components analysis

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; PROTHROMBIN;

ACIDOSIS; ACUTE LUNG INJURY; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; FIBRINOLYSIS; HUMAN; INJURY; INJURY SEVERITY; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; PENETRATING TRAUMA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHOCK; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; ANTITHROMBIN III; BLOOD COAGULATION DISORDERS; BRAIN INJURIES; FACTOR IX; FACTOR V; FACTOR VII; FACTOR VIII; FACTOR X; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INJURY SEVERITY SCORE; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; PROTEIN C; PROTHROMBIN; WOUNDS AND INJURIES; WOUNDS, PENETRATING;

EID: 84877048057     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31828b7fa1     Document Type: Article

References (21)

1. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748-754.
2. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245:812-818.
3. Cohen MJ, Call M, Nelson M, et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2011.
4. Baker SP, O'Neill B, HaddonWJr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
5. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(Pt 1):818-824.
6. Sauaia A, Moore EE, Johnson JL, Ciesla DJ, Biffl WL, Banerjee A. Validation of postinjury multiple organ failure scores. Shock. 2009; 31:438-447.
7. Linting M, Meulman JJ, Groenen PJ, van der Koojj AJ. Nonlinear principal components analysis: introduction and application. Psychol Methods. 2007;12:336-358.
8. Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular traumaVa unified approach. J Trauma. 1982;22:672-679.
9. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011;71(Suppl 1):S427-S434.
10. Duchesne JC, Holcomb JB. Damage control resuscitation: addressing trauma-induced coagulopathy. Br J Hosp Med (Lond). 2009;70:22-25.
11. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447-458.
12. Johansson PI, Sorensen AM, Perner A, et al. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 2011.
13. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194-200.
14. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204:2439-2448.
15. Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.JTrauma. 2011;71(Suppl 1):S435-S440.
16. Schochl H, Voelckel W, Maegele M, Solomon C. Trauma-associated hyperfibrinolysis. Hamostaseologie. 2012;32:22-27.
17. Kutcher ME, Cripps MW, McCreery RC, et al Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012;73:87-93.
18. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2011.
19. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23-32.
20. Nunnally JO. Psychometric Theory. New York, NY: McGraw-Hill; 1978.
21. Tabachnik BG, Fidell LS. Using Multivariate Statistics. 5th ed. Boston, MA: Pearson Education; 2007.